With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Pediatric Sarcoma, Rhabdomyosarcoma, and Mechanisms of Origin||University of Texas Southwestern Medical Center / Rene Galindo||'A' Award Grants||2010||Texas|
|DICER1-Driven Cancers: Models, Mechanisms and Therapies||University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD||Innovation Grants||2016||Texas|
|Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity||University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD||Innovation Grants||2018||Texas|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Holly Lindsay, MD/MS, Sarah Injac, MD||Center of Excellence Grants||2012||Texas|
|High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy||Baylor College of Medicine / Xavier Rios, MD/PhD||Young Investigator Grants||2020||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|
|Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma||Baylor College of Medicine / Jason Yustein, MD/PhD||Innovation Grants||2018||Texas|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma||Baylor College of Medicine / Jason T. Yustein, MD, PhD||Young Investigator Grants||2013||Texas|